Cancer Blog
- Dr. Robert Nagourney -

Personalized cancer therapy is the right treatment, at the right dose for the right patient. Like the weather, however, it seems that...

I sometimes joke with my patients that a new diagnosis of cancer rarely provides them enough time to get an MD or PhD. Yet it is that...

Cancer patients and their physicians can find themselves at the wrong end of many scientific discoveries. For example, the drug...

Our recent presentation at the American Association for Cancer Research meeting reported our work with a novel class of compounds known...

I recently returned from the American Association for Cancer Research (AACR) meeting held in Philadelphia. AACR is attended by basic...

The March 29, 2016 Wall Street Journal reported a 23-year-old man with acute myeloid leukemia (AML). Using genomic (DNA) profiling a...

I recently had the opportunity to meet two charming young patients: One, a 32-year-old female with an extremely rare malignancy that...

Ken Burn’s series “The Emperor of All Maladies” from Siddhartha Mukherjee’s book of the same title provides an interesting and...

This Saturday, April 4, my interview on CCTV's program FULL FRAME will be aired. The Mike Walters interview focuses on my study of human...

A 42 year old gentleman presented in 2003 with an aggressive prostate cancer. He underwent surgery, radiation, hormones, chemotherapy,...

Over the past decades oncologists have learned that cancer is driven by circuits known as signal transduction pathways. The first...

A report published in Cell from Dana-Farber Cancer Institute describes a technique to measure drug induced cell death in cell lines and...

An E-Publication article in the February Journal of Clinical Oncology analyzes the cost efficacy of Bevacizumab for colon cancer....

In 2005, as the Iraq War reached a low point with casualties mounting and public support dwindling, Sunni tribesman in the Anbar Province...

With the interest in “value oncology” and cost containment, a report appeared in the December 2014 Journal of Clinical Oncology that...

Disturbing news from Britain’s Health Service on Monday, January 12, described the National Health Services’ decision to “delist” 25 of...

Coco Chanel, the icon of 20th century fashion once said, “Only those with no memory insist on their originality.” I am reminded of this...

With the profusion of new targeted agents entering the clinical arena, a report from the American Society of Hematology bears...

Researchers from the Huntsman Cancer Institute at the University of Utah reported an interesting finding with far-reaching implications....